Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Karus Therapeutics (United Kingdom) | Researchclopedia

Back to institutions

Karus Therapeutics (United Kingdom)

Didcotcompany

80

Works

4,522

Citations

44

h-index

Top Research Topics

Histone Deacetylase Inhibitors Research PI3K/AKT/mTOR signaling in cancer Protein Degradation and Inhibitors

Top Researchers

Gordon B. Mills Baylor College of Medicine

3,472 works263,330 citationsh-index: 231

Recent Research

POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib

Pankit Vachhani,Abdulraheem Yacoub,et al.

20260 citations

Peptidase Inhibition and Analysis

Chronic Lymphocytic Leukemia Research

Animal Disease Management and Epidemiology

Virology and Viral Diseases

Vector-Borne Animal Diseases

Lymphoma Diagnosis and Treatment

Lung Cancer Treatments and Mutations

Cancer-related Molecular Pathways

Advanced Breast Cancer Therapies

Minoru Yoshida RIKEN Center for Sustainable Resource Science

1,947 works61,670 citationsh-index: 115

James R. Wright Duke University

1,444 works54,677 citationsh-index: 116

Paul Workman Institute of Cancer Research

1,183 works46,003 citationsh-index: 106

Len Stephens Babraham Institute

225 works24,479 citationsh-index: 76

Phillip T. Hawkins Babraham Institute

257 works23,979 citationsh-index: 76

A multivalent nanobody–drug conjugate to prevent and treat influenza virus infections

Thibault J. Harmand,Laura Pietrok,et al.

20253 citations

CAR-T cells co-targeting BCMA and CD19 in RRMM: Results from the UKMRA Phase 1 MCARTY trial in relapsed refractory multiple myeloma

Lydia Lee,Amatta Mirandari,et al.

20250 citations

Abstract A085: OBP-004, a novel small-molecule dual inhibitor of CDK9/13, reduces bone, brain, lung and lymph node metastases in vivo, with highest potency on bone metastases

Tiina E. Kähkönen,Gergana Galabova,et al.

20250 citations

NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines

Mariona Estapé Sentí,Alexandre Ceccaldi,et al.

202513 citations

Abstract 3295: Pharmacological characterization of CYRS1542: A potent and orally available GSPT1 molecular glue degrader for the treatment of neuroendocrine solid cancer with a favorable safety profile

Min Sung Joo,JaeYung Lee,et al.

20242 citations